- Danaher posted a temporary weakness on its topline growth which snowballed to its margins.
- It enjoys opportunities outside the pandemic which will support its topline growth.
- The company generates liquidity better than its historic level and its peer, Thermo Fisher Scientific.
- It enjoys a declining number of preferred shares which will free up annual cash obligations of the company.
- This stock is trading near logical supports, is trading at lower multiples than its five-year average and is trading at a discount to its intrinsic value.
For further details see:
Danaher Remains Stable And Better Than Its Pre-Pandemic Level